Research Summary

Dr. Robert E. Goldsby is a pediatric cancer specialist at UCSF Benioff Children's Hospitals. He directs the UCSF Survivors of Childhood Cancer Program, which provides care and long-term follow-up for patients who had cancer in childhood. One of his particular areas of interest is treating young patients with high-risk sarcomas.

Goldsby has received numerous awards and grants, including grants from the American Cancer Society and Hope Street Kids.

    Research Funding

    • September 17, 1997 - August 31, 2002 - POLYMERASE PROOFREADING AND MUTAGENESIS , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K08CA072731


    University of California, Berkeley, B.A., 1985, Neurobiology
    University of Vermont, Burlington, M.D., 1991, Medicine

    Honors & Awards

    • 1988
      Summer Research Fellowship Award
    • 1992
      Diplomat, National Board of Medical Examiners (#404330)American Cancer Society
    • 1994
      Certified, American Board of Pediatrics (#237231)
    • 1994-95
      American Cancer Society Clinical Fellowship Award (94-220-1)
    • 1995
      Fellow, American Association of Cancer Research Molecular Biology Workshop
    • 1995-96
      NSRA Institutional Training Grant ( 2 T32 DKO7115-21)
    • 1996-97
      Leukemia Society of America Fellowship Research Grant (5119-97)
    • 1997-02
      Mentored Clinical Scientist Development Award (K08-CA72731)
    • 1999
      Certified, Pediatric Hem/Onc Subspecialty Board
    • 1999
      University of Utah Seed Grant
    • 1999
      Young Investigator, American Association of Cancer Research Clinical Trial Development Workshop
    • 2001-02
      Hope Street Kids Grant
    • 2001-03
      American Cancer Society Grant (RPG-00-299-01-GMC)
    • 2002
      Summer Clinical Research Workshop July 30 September 12
    • 2002-03
      Advanced Training in Clinical Research (ATCR) Certificate Program
    • 2011
      Compassionate Physician Award
    • 2013
      Exceptional Physician Award
    • 2013
      Stephanie Berman Award. UCSF Department of Social Work
    • 2014
      Faculty Leadership Award

    Selected Publications

    1. Bhatia S, Pappo AS, Acquazzino M, Allen-Rhoades WA, Barnett M, Borinstein SC, Casey R, Choo S, Chugh R, Dinner S, Ermoian R, Fair D, Federman N, Folbrecht J, Gandhi S, Germann J, Goldsby R, Hayashi R, Huang AY, Huang MS, Jacobs LA, Lee-Miller C, Link MP, Livingston JA, Lustberg M, Malogolowkin M, Oeffinger KC, Pratilas CA, Reed D, Skiles J, von Mehren M, Yeager N, Montgomery S, Hang L. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 08; 21(8):851-880.  View on PubMed
    2. Geiger EJ, Liu W, Srivastava DK, Bernthal NM, Weil BR, Yasui Y, Ness KK, Krull KR, Goldsby RE, Oeffinger KC, Robison LL, Dieffenbach BV, Weldon CB, Gebhardt MC, Howell R, Murphy AJ, Leisenring WM, Armstrong GT, Chow EJ, Wustrack RL. What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report. Clin Orthop Relat Res. 2023 03 01; 481(3):526-538.  View on PubMed
    3. Stroud SG, Geiger EJ, Lichtensztajn DY, Goldsby RE, Cheng I, Wustrack R, Theologis AA. Survival of Patients With Primary Osseous Malignancies of the Mobile Spine Is Associated With Access to "Standard Treatment" Protocols. J Am Acad Orthop Surg. 2022 Sep 01; 30(17):841-850.  View on PubMed
    4. Pyke-Grimm KA, Franck LS, Halpern-Felsher B, Goldsby RE, Rehm RS. Day-to-Day Decision Making by Adolescents and Young Adults with Cancer. J Pediatr Hematol Oncol Nurs. 2022 Sep-Oct; 39(5):290-303.  View on PubMed
    5. Sarah Stroud, Erik J. Geiger, Daphne Lichtensztajn, Robert Goldsby, Iona Cheng, Rosie Wustrack, Alexander A. Theologis. P76. An analysis of prognostic factors for patients with primary osseous malignancies of the mobile spine in the California Cancer Registry, 1988-2016. The Spine Journal. 2021 Sep 1; 21(9):s176-s177.  View on PubMed
    6. Dieffenbach BV, Liu Q, Murphy AJ, Stein DR, Wu N, Madenci AL, Leisenring WM, Kadan-Lottick NS, Christison-Lagay ER, Goldsby RE, Howell RM, Smith SA, Oeffinger KC, Yasui Y, Armstrong GT, Weldon CB, Chow EJ, Weil BR. Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2021 09; 155:216-226.  View on PubMed
    7. Rees HD, Hills NK, Sabnis AJ, Tulpule AB, Shimotake TK, Goldsby RE. Clinical characteristics and outcomes of infants compared with children diagnosed with rhabdomyosarcoma: Analysis of surveillance, epidemiology and end results data from 2000 to 2016. Cancer Rep (Hoboken). 2022 05; 5(5):e1503.  View on PubMed
    8. Pyke-Grimm KA, Franck LS, Halpern-Felsher B, Goldsby RE, Rehm RS. 3 Dimensions of Treatment Decision Making in Adolescents and Young Adults With Cancer. Cancer Nurs. 2020 Nov/Dec; 43(6):436-445.  View on PubMed
    9. Lavergne V, Sabnis A, Tupule A, Davidson PR, Kline C, Matthay K, Nicolaides T, Goldsby R, Braunstein S, Fogh SE, Sneed PK, Menzel P, Nakamura A, DuBois SG, Haas-Kogan DA, Nakamura JL. Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy. J Pediatr Hematol Oncol. 2020 10; 42(7):e647-e654.  View on PubMed
    10. Lucas TL, Mustain R, Goldsby RE. Frequency of face touching with and without a mask in pediatric hematology/oncology health care professionals. Pediatr Blood Cancer. 2020 09; 67(9):e28593.  View on PubMed
    11. Murphy P, Levine A, Lerma T, Young S, Hwang J, Goldsby R. A portable survivorship care plan: a tool that helps educate and improve knowledge in childhood cancer survivors. Support Care Cancer. 2021 Jan; 29(1):169-177.  View on PubMed
    12. Penumarthy NL, Goldsby RE, Shiboski SC, Wustrack R, Murphy P, Winestone LE. Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas. Cancer Med. 2020 02; 9(3):951-958.  View on PubMed
    13. Dirksen U, Brennan B, Le Deley MC, Cozic N, van den Berg H, Bhadri V, Brichard B, Claude L, Craft A, Amler S, Gaspar N, Gelderblom H, Goldsby R, Gorlick R, Grier HE, Guinbretiere JM, Hauser P, Hjorth L, Janeway K, Juergens H, Judson I, Krailo M, Kruseova J, Kuehne T, Ladenstein R, Lervat C, Lessnick SL, Lewis I, Linassier C, Marec-Berard P, Marina N, Morland B, Pacquement H, Paulussen M, Randall RL, Ranft A, Le Teuff G, Wheatley K, Whelan J, Womer R, Oberlin O, Hawkins DS, Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. J Clin Oncol. 2019 12 01; 37(34):3192-3202.  View on PubMed
    14. Neela Lakshmi Penumarthy, Robert Goldsby, Lena Penumarthy. Impact of low-income public insurance on survival for children and young adults with bone and soft tissue sarcomas. Journal of Clinical Oncology. 2019 May 20; 37(15_suppl):10037-10037.  View on PubMed
    15. Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019 03; 109:36-50.  View on PubMed
    16. Pyke-Grimm KA, Franck LS, Patterson Kelly K, Halpern-Felsher B, Goldsby RE, Kleiman A, Rehm RS. Treatment Decision-Making Involvement in Adolescents and Young Adults With Cancer. Oncol Nurs Forum. 2019 01 13; 46(1):E22-E37.  View on PubMed
    17. Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Hingorani P, Collier A, Morris CD, Kolb EA, Doski JJ, Womer RB, Gorlick R, Janeway KA. A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2019 02; 66(2):e27524.  View on PubMed
    18. Coccia PF, Pappo AS, Beaupin L, Borges VF, Borinstein SC, Chugh R, Dinner S, Folbrecht J, Frazier AL, Goldsby R, Gubin A, Hayashi R, Huang MS, Link MP, Livingston JA, Matloub Y, Millard F, Oeffinger KC, Puccetti D, Reed D, Robinson S, Rosenberg AR, Sanft T, Spraker-Perlman HL, von Mehren M, Wechsler DS, Whelan KF, Yeager N, Gurski LA, Shead DA. Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Jan; 16(1):66-97.  View on PubMed
    19. Goldsby RE, Stratton KL, Raber S, Ablin A, Strong LC, Oeffinger K, Sklar CA, Armstrong GT, Robison LL, Bhatia S, Leisenring WM. Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report. Cancer. 2018 02 01; 124(3):617-625.  View on PubMed
    20. Eric Chang, Robert Goldsby, Sabine Mueller, Anu Banerjee. Late Effects of Treatment and Palliative Care. Pediatric CNS Tumors. 2017 Jan 1; 365-387.  View on PubMed

    Go to UCSF Profiles, powered by CTSI